title: Effects of 32P radioactive stents on in-stent restenosis in a double stent injury model of the porcine coronary arteries.
abstract: BACKGROUND
  The major limitation of coronary stenting remains in-stent restenosis, due to the development of neointimal proliferation. Radioactive stents have demonstrated the ability to reduce this proliferation in the healthy nonatherosclerotic porcine animal model. However, inhibition of tissue proliferation in the in-stent restenotic lesion in a porcine model is not well characterized. The objective of this study was to examine the efficacy and safety of the 32P radioactive stent for the treatment of in-stent restenosis in a double stent injury model of the porcine coronaries.
  
  
  METHODS
  Eighteen coronary arteries in 9 pigs underwent nonradioactive stent (8 mm in length) implantation. Thirty days after the initial stent implantation, a 32P radioactive stent (18 mm in length) with an activity of 0 and 18 microCi was implanted to cover the initial stent. The swine were killed 30 days after the second stent implantation. Histomorphometric analysis was performed for vessel area (VA), stent strut area (SSA), intimal area (IA), and lumen area (LA).
  
  
  RESULTS
  Injury scores, VA, SSA, and LA were similar among the control and radiated groups. Neointimal formation was significantly reduced after placement of radioactive stents as compared to control in both the overlapped (0.93 +/- 0.12 vs. 1.31 +/- 0.51 mm(2), p < 0.05) and nonoverlapped segments (1.14 +/- 0.21 vs. 1.91 +/- 1.04 mm(2), p < 0.05). The smooth muscle cell index in the neointima was reduced. Intimal fibrin was increased in the radiated group as compared to the control (p < 0.01 respectively).
  
  
  CONCLUSIONS
  32P radioactive stents may be safe and effective in reducing neointimal formation leading to in-stent restenosis. Longer follow-up will be required to examine whether these positive findings can be maintained.
authors.affiliation: Cardiovascular Research Institute, Washington Hospital Center, Washington, DC 20010, USA.
authors.forename: H S
authors.initials: HS
authors.lastname: Kim
authors.forename: R C
authors.initials: RC
authors.lastname: Chan
authors.forename: M
authors.initials: M
authors.lastname: Kollum
authors.forename: A
authors.initials: A
authors.lastname: Au
authors.forename: F O
authors.initials: FO
authors.lastname: Tio
authors.forename: H A
authors.initials: HA
authors.lastname: Yazdi
authors.forename: A E
authors.initials: AE
authors.lastname: Ajani
authors.forename: R
authors.initials: R
authors.lastname: Waksman
mesh_terms: D000818:Animals; D023903:Coronary Restenosis / Q000473:pathology / Q000517:prevention & control*; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use*; D015607:Stents; D013552:Swine; D017539:Tunica Intima / Q000528:radiation effects
chemical_list: D010761:Phosphorus Radioisotopes